MIRA JANINE HENSON: Open Payments
NPI 1104500735 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 73 payments from 20 companies in 2025. Trend: 2023 $494 · 2024 $3,276 · 2025 $1,608
Food & beverage: $1,608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $590 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| PFIZER INC. | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| UCB, Inc. | 3 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| ARGENX US, INC. | 5 | $84 |
| Lundbeck LLC | 3 | $44 |
| Aucta Pharmaceuticals, Inc. | 4 | $40 |
Products named: QULIPTA, UBRELVY, HYQVIA, NURTEC ODT, REXULTI, Rystiggo, KESIMPTA, AUSTEDO XR.
Industry payments across NV — which companies pay providers there.
